作者: Ronen Rabinowitz , Gabriel Katz , Mordechai Rosner , Sara Pri-Chen , Abraham Spierer
DOI: 10.1007/S00417-008-0781-Z
关键词:
摘要: Purpose Abnormal angiogenesis is the hallmark feature of retinopathy prematurity (ROP), and contributes to severe visual loss that accompanies this disease. Thalidomide a well-known anti-angiogenic drug. We tested assumption injection intraperitoneal thalidomide could reduce severity oxygen-induced (OIR) in mouse model.